Press Release
Business

Cardiac Biomarkers Testing Market 2019-2026: Key Player, Demand, Growth, Opportunities and Forecast

A new market research report on the Global Cardiac Biomarkers Testing market has introduced by KD Market Insights. The report is dedicated to in-depth industry analysis of the global Cardiac Biomarkers Testing market. The Global Cardiac Biomarkers Testing  analysis is broken down on different segmentation levels including Market By Type, By Application, By Location of Testing.

The global cardiac biomarker market generated $7,638 million in 2018, and is projected to reach $18,232 million by 2026, growing at a CAGR of 11.4%. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state as well as for diagnostic and prognostic purposes associated with heart. The prevention of cardiac diseases by monitoring heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS), and others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA, and others. The global cardiac biomarkers testing market has witnessed a greater demand over the past five to six years.

Get Report Sample Copy @ https://www.kdmarketinsights.com/sample/5297
 
The ability of cardiac markers for accurate and rapid prediction of heart failure after the onset of chest pain acts as a key factor that boosts the growth of the global cardiac market. In addition, promising features such as high accuracy, quick outcomes, and economic pricing of cardiac point of care (POC) testing drive the market growth. To keep the momentum of cardiac marker tests, key manufacturers offer customized solutions, thus propelling the growth of the market. The commercial application of multi-menu options for cardiac testing using different combinations of cardiac biomarkers and target-oriented solutions serves as the key opportunity for market expansion. However, limited specificity in some cases and side effects such as skeletal muscle injury restrains the growth of the cardiac biomarkers testing market.

The global cardiac biomarker market is segmented based on type, application, location of testing, and region. By type, the market is fragmented into myocardial muscle creatine kinase (CK-MB), troponins (T and I), myoglobin, brain natriuretic peptide (BNPs) or NT-proBNP, ischemia modified albumin (IMA), and others. Depending on application, it is categorized into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. By location of testing, it is bifurcated into point of care testing and laboratory testing. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
– This report highlights the market dynamics to understand the global cardiac biomarker market and capitalize on the prevailing opportunities.
– Quantitative analysis of the current market and forecasts assists stakeholders to design business strategies accordingly.
– Porter’s five forces analysis examines the competitive market structure and provides a deeper understanding of the influencing factors for entry and expansion.
– Pin-point analysis of geographical segments offers identification of most profitable segments to capitalize on.

KEY MARKET SEGMENTS

By Type
– Myocardial Muscle Creatine Kinase (CK-MB)
– Troponins (T and I)
– Myoglobin
– Brain Natriuretic Peptide (BNPs) or NT-proBNP
– Ischemia-modified Albumin (IMA)
– Others

By Application
– Myocardial Infarction
– Congestive Heart Failure
– Acute Coronary Syndrome
– Atherosclerosis
– Others

By Location of Testing
– Point of Care Testing
– Laboratory Testing

By Region
North America
– U.S.
– Canada
– Mexico
Europe
– Germany
– France
– Spain
– Italy
– UK
– Rest of Europe
Asia-Pacific
– Australia
– Japan
– India
– China
– Rest of Asia-Pacific
LAMEA
– Latin America
– Middle East
– Africa

KEY MARKET PLAYERS
– Roche Diagnostics
– Abbott Laboratories
– Siemens Healthcare
– Becton, Dickinson and Company
– Bio-Rad Laboratories
– BioMerieux
– PerkinElmer Inc.
– Tosoh Corporation
– Danaher Corporation
– Thermo Fisher Scientific

Access Complete Research Report with TOC @ https://www.kdmarketinsights.com/product/cardiac-biomarkers-testing-market-amr

Table of Content

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings
2.1.1. Top impacting factors
2.1.2. Top investment pockets
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Biomarker diagnosis vs. conventional diagnosis
3.3. Assessment of key advantages and buying criteria for diagnostic biomarkers
3.3.1. Early diagnosis
3.3.2. Tissue specific diagnosis
3.3.3. Reduce clinical trials
3.3.4. Consistent output
3.4. Key trends impacting the Cardiac biomarker testing market
3.4.1. Development of high sensitive biomarkers for risk stratification
3.4.2. Technological advancements in the cardiac biomarkers: Serum based biomarkers
3.4.3. Increasing demand for point of care cardiac diagnostics
3.5. Parent Market Overview
3.6. Key Forces Shaping Cardiac biomarker testing market
3.6.1. High bargaining power of suppliers
3.6.2. Low bargaining power of buyers
3.6.3. Low threat of new entrants
3.6.4. Low threat of substitutes
3.6.5. High intensity of rivalry
3.7. Value chain analysis
3.8. Pricing Analysis
3.8.1. Pricing Analysis, By Region, 2018 & 2025
3.9. Market evolution/Industry roadmap
3.10. Government regulations
3.11. Reimbursement issues
3.12. Patent Analysis
3.12.1. By Region (2016-2018)
3.12.2. By Applicant
3.13. Market share analysis
3.14. Case Studies
3.14.1. Case Study
3.15. Market dynamics
3.15.1. Drivers
3.15.1.1. Increasing prevalence of cardiovascular diseases
3.15.1.2. Cost effective
3.15.1.3. Non-invasive
3.15.1.4. Accuracy prediction
3.15.1.5. Technological advancements using cardiac biomarkers combinations
3.15.1.6. Increasing point of care (POC) testing
3.15.2. Restraints
3.15.2.1. Government Regulation
3.15.2.2. Conformation in result
3.15.2.3. Complex process
3.15.3. Opportunities
3.15.3.1. Personalized medicine
3.15.3.2. Point of care (POCT) testing using cardiac biomarkers

CHAPTER 4: CARDIAC BIOMARKER TESTING MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Creatine kinase (CK-MB)
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Troponins
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Myoglobin
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Natriuretic peptides (BNP and NT-proBNP)
4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Ischemia modified albumin
4.6.1. Key market trends and opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country
4.7. Others
4.7.1. Key market trends and opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country

CHAPTER 5: CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Myocardial infarction
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Congestive heart failure
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Acute coronary syndrome
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Atherosclerosis
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
5.6. Other applications
5.6.1. Market size and forecast
5.6.2. Market analysis, by country

Continue @…
 
Check for Discount @ https://www.kdmarketinsights.com/discount/5297
 
About Us:
 
KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.
 
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: [email protected]
Website: www.kdmarketinsights.com
https://marketreserachtab.blogspot.com/
http://kdmarketinsights.blogspot.com/